Source comparison
NAD+ Peptide vs NAD+: What's the Real Difference? | Real Peptides
Those small peptide vials labeled 'NAD+ boosters' sitting in research freezers don't contain NAD+. And that's exactly the point. Research from Harvard Medical School found that oral NAD+ has less than 5% bioavailability because the 663 Da molecule can't cross
This comparison does not assign a generated winner or score.
- Those small peptide vials labeled 'NAD+ boosters' sitting in research freezers don't contain NAD+. And that's exactly the point. Research from Harvard Medical School found that oral NAD+ has less than 5% bioavailability because the 663 Da molecule can't cross intestinal epithelial cell membranes intact. What works instead are smaller precursor molecules. NMN (nicotinamide mononucleotide), NR (nicotinamide riboside), and peptide-based NAD+ precursors. That slip through cellular barriers and trigger endogenous NAD+ synthesis inside the cell.
- Our team works with research institutions sourcing these compounds for cellular aging studies. The confusion between 'NAD+ peptide' and 'NAD+' isn't semantic. It's the difference between a molecule that works and one that doesn't.
- Is NAD+ peptide the same as NAD+?
- No. NAD+ peptides are biosynthetic precursors like NMN or NR, not the NAD+ coenzyme itself. These precursors are smaller molecules (typically 300–350 Da) that cross cell membranes and convert to NAD+ intracellularly through salvage pathway enzymes like NMNAT (nicotinamide mononucleotide adenylyltransferase). Direct NAD+ supplementation fails because the 663 Da dinucleotide cannot efficiently penetrate lipid bilayers, resulting in less than 5% systemic bioavailability even with high-dose oral or IV administration.
- Most research protocols don't use NAD+ directly. They use the precursors. The term 'NAD+ peptide' is shorthand for a class of compounds that raise intracellular NAD+ levels without being NAD+ themselves. This article covers the biosynthetic mechanism that makes precursors work, why direct NAD+ fails at the cellular level, and what peptide researchers actually mean when they reference NAD+ compounds in protocol documentation.